T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

A Stanford Medicine trial has shown success with CAR-T cell therapy in shrinking deadly childhood brain tumors. For one ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

▎药明康德内容团队编辑  12年前，一名不到7岁的小女孩急性淋巴细胞白血病复发，危在旦夕。幸运的是，她接受了一项史无前例的治疗——医生们从她的身体里分离出一部分T细胞，先在实验室里对其进行基因改造，让这些细胞有能力识别癌细胞；随后，改造后的T细胞经过 ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

In a recent study published in Nature, a team of scientists from Stanford University investigated the potential of chimeric ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...